Home/Pipeline/IV-Cell

IV-Cell

Cell Culture for Hematologic Malignancies

Research/DevelopmentDevelopment

Key Facts

Indication
Cell Culture for Hematologic Malignancies
Phase
Research/Development
Status
Development
Company

About Precipio

Precipio is dedicated to transforming cancer diagnostics by addressing the critical issue of diagnostic error through its specialized laboratory services and proprietary technologies. The company has built a commercial laboratory operation offering a comprehensive menu of tests, including flow cytometry, cytogenetics, fluorescence in situ hybridization (FISH), and molecular diagnostics. Its strategic direction involves leveraging its expertise in complex diagnostics to capture market share in the underserved niche of accurate, rapid-turnaround cancer testing, while exploring the development of novel diagnostic platforms.

View full company profile

Therapeutic Areas